Parents’ concerns about their children’s safety are understandable and legitimate. With the recent publication of an important study in Environmental Health journal, and the consequent words from Trump, it’s necessary to clarify what the scientific research really tells us about paracetamol, also known as acetaminophen autism, and neurodevelopmental disorders.
Key Points
- Acetaminophen remains the preferred analgesic drug during pregnancy
- If the association found in this study were confirmed as causal, the absolute risks remain relatively low
- Current recommendations for acetaminophen use in pregnancy remain unchanged
Acetaminophen Autism: Is It True?
A new study published in 2025 used the Navigation Guide methodology to systematically examine 46 scientific studies on the relationship between acetaminophen use during pregnancy and neurodevelopmental disorders like ADHD, autism, and other related problems.
The results show fairly consistent evidence of association (which is not causation, and this is very important to keep in mind) between prenatal acetaminophen exposure and an increased risk of these disorders.
However, it’s essential to understand what this evidence really means and how to interpret it correctly, and that’s what we’ll do together.
The 2025 Navigation Guide Study: A Methodological Breakthrough
The study by Prada et al., published in Environmental Health in 2025, is so far the most rigorous systematic analysis ever conducted on this topic. Using the Navigation Guide methodology – specifically designed to evaluate scientific evidence in environmental health – the researchers examined 46 peer-reviewed studies, including more than 4 million total participants, which is an excellent number for a review. This represents an important statistical sample.
Main results of the study:
- Of 20 ADHD studies: 14 showed positive associations, 3 null, and 1 inverse
- Of 8 autism studies: 5 showed positive associations, 2 null, and 1 mixed
- Of 18 studies on other neurodevelopmental disorders: 6 positive, 4 inverse, 2 null, and 6 mixed
What’s important to keep in mind is that higher-quality studies were more likely to show positive associations, suggesting that the results are not due to methodological limitations, but reflect a possible real relationship.
Evidence of Dose-Response Relationship and Biological Mechanisms
The study identified evidence of a dose-response relationship.
What does this mean? It means that the greater the exposure to acetaminophen during pregnancy, the greater the observed risk. This is one of the characteristics that epidemiologists use to evaluate whether a statistical association might indicate a causal relationship.
The researchers also examined possible biological mechanisms:
- Placental barrier crossing: acetaminophen freely crosses the placenta, reaching levels in the fetal circulation similar to maternal levels within less than an hour of maternal ingestion.
- Effects on the developing brain: the drug can produce toxic metabolites in the fetal brain through the CYP2E1 enzyme, present in the fetal brain, placenta, and lungs. The developing brain is particularly vulnerable to oxidative stress because it grows rapidly and needs a lot of energy metabolism.
- Endocrine interference: acetaminophen acts as an endocrine disruptor, altering hormone-dependent processes crucial for neurological development.
- Epigenetic alterations: prenatal exposure is associated with changes in DNA methylation in fetal tissues and placenta, including loci vital for neurodevelopment.
It’s very important, however, not to be overwhelmed by these technical terms and all these details, because there are some very important limitations to discuss and, above all, to understand the context well before drawing conclusions.
We parents are not researchers, we live in the real world, and the real world is often more complex than scientific citations. In this world, we often have to make risk-benefit evaluations that favor one choice over another.
Let’s see together what limitations the study cited by the orange-haired president has.
Study Limitations and Controversies on Sibling-Controlled Designs
It’s important to note that the study identified some significant limitations in studies that don’t find associations. In particular, three “sibling-controlled” studies (which compare siblings within the same family) showed null results, but present important methodological problems:
- Exposure underestimation problems: the Swedish study by Ahlqvist et al. reported only 7.5% acetaminophen use among pregnant women, much lower than the 50-60% reported globally and by other Swedish studies from the same period. This suggests substantial misclassification of exposure.
- Reduced statistical power: sibling-controlled studies have very small samples for the final analysis. For example, the Gustavson et al. study had only 34 sibling pairs discordant for long-term exposure.
- Possible introduced biases: while these designs eliminate some familial confounding factors, they may also eliminate potential biological mediators that operate at the family level, paradoxically introducing new biases.
The Harms of Medical Misinformation on Families
The spread of inadequately verified medical information has documented and measurable consequences on public health and family well-being.
Research shows that parents exposed to medical misinformation develop chronic anxiety, unfounded guilt, and tend to avoid necessary medical treatments for their children (for example, vaccines).
In the specific case of autism, misinformation about alleged causal factors leads 60-70% of parents to feel responsible for their child’s condition.
This sense of guilt is not only scientifically unfounded, but generates chronic stress, social isolation, and can delay access to early therapeutic interventions that are crucial for the child’s development.
Families spend an average of 3,000-10,000 dollars annually on non-scientific autism treatments, resources that could be better invested in evidence-based therapies.
Unfounded fear of medications also leads to immediate consequences: emergency room visits for untreated high fevers increase and suffering during common childhood illnesses is unnecessarily prolonged.
So What Should I Do?
The 2025 study concludes with balanced recommendations that recognize both emerging risks and established benefits of acetaminophen:
For healthcare professionals:
- Inform pregnant women about potential risks and benefits
- Recommend “judicious” use of acetaminophen: lowest effective dose, shortest possible duration (which are already current recommendations, and the reasons why acetaminophen is considered safe in pregnancy)
- Consider non-pharmacological alternatives when appropriate (for example, physical cooling for fever)
- Maintain medical consultation for individualized decisions
Can I Use It or Not?
Acetaminophen remains the preferred analgesic drug during pregnancy, given that NSAIDs (non-steroidal anti-inflammatory drugs) present established teratogenic risks, especially in the third trimester.
However, use should be limited to situations where it’s really necessary, avoiding routine or prolonged use without medical supervision.
It’s important to emphasize that even if the association found in this study were confirmed as causal, the absolute risks remain relatively low. Studies show relative risk increases ranging from 20% to 50%, but on an already very low baseline in the general population.
Why It’s Important to Know How to Evaluate Information
If the 2025 Navigation Guide study represents a turning point in understanding the relationship between acetaminophen and neurodevelopmental disorders, we need to understand it fully.
Yes, for the first time, we have a rigorous and systematic synthesis of all available evidence, indicating a consistent association between prenatal acetaminophen use and increased risk of ADHD, autism, and other neurodevelopmental disorders.
However, it’s essential to maintain the correct perspective:
What we know now:
- Quality scientific evidence exists for an association
- The association is supported by biological plausibility
- Better quality studies show more consistent results
- Evidence of dose-response relationship exists
What we still don’t know:
- Whether the association is definitively causal
- What the exact mechanisms involved are
- How to precisely quantify individual risk
- What the most critical time windows are
How You Should Behave
- Don’t avoid acetaminophen when necessary – high fever and severe pain require treatment
- Use judiciously – minimum effective dose, shortest possible duration
- Always consult your doctor for personalized decisions
- Consider non-pharmacological alternatives when appropriate
- Don’t develop guilt for necessary past uses
We Are With You
As informed parents, we must learn to live with scientific uncertainty, making decisions based on the best available evidence rather than unfounded fears or overly simplistic reassurances.
The final message is clear: acetaminophen remains an important and relatively safe drug, but deserves more conscious and targeted use during pregnancy, always under appropriate medical supervision.
We at Parentalife support you throughout the entire parenting journey with guides, courses, and with personalized consultations.
We are with you.
SOURCES
Prada, D., Ritz, B., Bauer, A.Z. et al. Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology. Environ Health 24, 56 (2025). https://doi.org/10.1186/s12940-025-01208-0